awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37945643-B91BE471-AAD3-4CF1-B207-46EB466BC1D0
Q37945643-B91BE471-AAD3-4CF1-B207-46EB466BC1D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37945643-B91BE471-AAD3-4CF1-B207-46EB466BC1D0
Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?
P2860
Q37945643-B91BE471-AAD3-4CF1-B207-46EB466BC1D0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37945643-B91BE471-AAD3-4CF1-B207-46EB466BC1D0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0cb3d3fcdae079b095ffb4eebc22df4c20f7542a
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).